| scholarly article | Q13442814 |
| review article | Q7318358 |
| P2093 | author name string | Timchenko LT | |
| P2860 | cites work | Cardiac elav-type RNA-binding protein (ETR-3) binds to RNA CUG repeats expanded in myotonic dystrophy | Q22008662 |
| Identification of a (CUG)n triplet repeat RNA-binding protein and its expression in myotonic dystrophy | Q24328773 | ||
| Altered phosphorylation and intracellular distribution of a (CUG)n triplet repeat RNA-binding protein in patients with myotonic dystrophy and in myotonin protein kinase knockout mice | Q24654728 | ||
| Myotonic dystrophy mutation: an unstable CTG repeat in the 3' untranslated region of the gene | Q28285882 | ||
| Novel proteins with binding specificity for DNA CTG repeats and RNA CUG repeats: implications for myotonic dystrophy | Q28288794 | ||
| Identification of two nuclear proteins which bind to RNA CUG repeats: significance for myotonic dystrophy | Q28296407 | ||
| Cloning of the essential myotonic dystrophy region and mapping of the putative defect | Q30985550 | ||
| Identification of HuR as a protein implicated in AUUUA-mediated mRNA decay | Q33886475 | ||
| Molecular basis of myotonic dystrophy: expansion of a trinucleotide (CTG) repeat at the 3' end of a transcript encoding a protein kinase family member. | Q33968674 | ||
| An unstable triplet repeat in a gene related to myotonic muscular dystrophy | Q34355359 | ||
| Decreased expression of myotonin-protein kinase messenger RNA and protein in adult form of myotonic dystrophy. | Q34363062 | ||
| A novel homeodomain-encoding gene is associated with a large CpG island interrupted by the myotonic dystrophy unstable (CTG)n repeat | Q34374463 | ||
| Hel-N1: an autoimmune RNA-binding protein with specificity for 3' uridylate-rich untranslated regions of growth factor mRNAs | Q36686295 | ||
| Genetic complementation reveals a novel regulatory role for 3' untranslated regions in growth and differentiation | Q36770883 | ||
| RNA metabolism in myotonic dystrophy: patient muscle shows decreased insulin receptor RNA and protein consistent with abnormal insulin resistance. | Q37365699 | ||
| Myotonic dystrophy: an unstable CTG repeat in a protein kinase gene. | Q40450041 | ||
| Disruption of splicing regulated by a CUG-binding protein in myotonic dystrophy | Q41041118 | ||
| Overexpression of 3'-untranslated region of the myotonic dystrophy kinase cDNA inhibits myoblast differentiation in vitro | Q41075540 | ||
| Overexpression of myotonic dystrophy kinase in BC3H1 cells induces the skeletal muscle phenotype | Q41240489 | ||
| Myotonic dystrophy: discussion of molecular mechanism | Q41553023 | ||
| The DMPK gene of severely affected myotonic dystrophy patients is hypermethylated proximal to the largely expanded CTG repeat | Q41968306 | ||
| Genetic mapping of a second myotonic dystrophy locus | Q47991794 | ||
| Abnormal myotonic dystrophy protein kinase levels produce only mild myopathy in mice. | Q52200997 | ||
| Positive autoregulation of sex-lethal by alternative splicing maintains the female determined state in Drosophila. | Q52448198 | ||
| Expansion of an unstable DNA region and phenotypic variation in myotonic dystrophy | Q55670526 | ||
| Myotonic dystrophy: evidence for a possible dominant-negative RNA mutation | Q60050804 | ||
| Effect of Myotonic Dystrophy Trinucleotide Repeat Expansion on DMPK Transcription and Processing | Q62661555 | ||
| Detection of an unstable fragment of DNA specific to individuals with myotonic dystrophy | Q67513917 | ||
| A liver-enriched transcriptional activator protein, LAP, and a transcriptional inhibitory protein, LIP, are translated from the same mRNA | Q68033053 | ||
| Mice lacking the myotonic dystrophy protein kinase develop a late onset progressive myopathy | Q71167717 | ||
| Fragile-X syndrome and myotonic dystrophy: parallels and paradoxes | Q74607477 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | myotonic dystrophy | Q1860507 |
| P304 | page(s) | 360-364 | |
| P577 | publication date | 1999-02-01 | |
| P1433 | published in | American Journal of Human Genetics | Q4744249 |
| P1476 | title | Myotonic dystrophy: the role of RNA CUG triplet repeats | |
| P478 | volume | 64 |
| Q24315754 | A defective Krab-domain zinc-finger transcription factor contributes to altered myogenesis in myotonic dystrophy type 1 |
| Q74441599 | Aberrant regulation of insulin receptor alternative splicing is associated with insulin resistance in myotonic dystrophy |
| Q41844296 | Biological implications of the DNA structures associated with disease-causing triplet repeats |
| Q35121604 | Cardiac Complications of Childhood Myopathies |
| Q47332454 | Correction of GSK3β at young age prevents muscle pathology in mice with myotonic dystrophy type 1. |
| Q92255896 | Correction of RNA-Binding Protein CUGBP1 and GSK3β Signaling as Therapeutic Approach for Congenital and Adult Myotonic Dystrophy Type 1 |
| Q34500408 | Daytime sleepiness and REM sleep characteristics in myotonic dystrophy: a case-control study |
| Q38083615 | Daytime sleepiness and myotonic dystrophy |
| Q73168300 | ETR-1, a homologue of a protein linked to myotonic dystrophy, is essential for muscle development in Caenorhabditis elegans |
| Q40714167 | Expanded CTG repeats inhibit neuronal differentiation of the PC12 cell line |
| Q34378929 | Expansion of CUG RNA repeats causes stress and inhibition of translation in myotonic dystrophy 1 (DM1) cells |
| Q37590296 | GSK3β is a new therapeutic target for myotonic dystrophy type 1. |
| Q36498042 | GSK3β mediates muscle pathology in myotonic dystrophy |
| Q50686246 | Highlights of alternative splicing regulation session: yes, no, maybe--a history of paradigm shifts. |
| Q28236888 | Inherited conduction system abnormalities--one group of diseases, many genes |
| Q28504484 | Mice deficient in Six5 develop cataracts: implications for myotonic dystrophy |
| Q24548314 | Molecular basis for impaired muscle differentiation in myotonic dystrophy |
| Q37138514 | Molecular mechanisms of muscle atrophy in myotonic dystrophies |
| Q34499428 | Molecular, physiological, and motor performance defects in DMSXL mice carrying >1,000 CTG repeats from the human DM1 locus |
| Q33867667 | Myotonic dystrophies 1 and 2: complex diseases with complex mechanisms. |
| Q28189260 | Novel role for RNA-binding protein CUGBP2 in mammalian RNA editing. CUGBP2 modulates C to U editing of apolipoprotein B mRNA by interacting with apobec-1 and ACF, the apobec-1 complementation factor |
| Q28140822 | RNA CUG repeats sequester CUGBP1 and alter protein levels and activity of CUGBP1 |
| Q35474587 | RNA Foci, CUGBP1, and ZNF9 are the primary targets of the mutant CUG and CCUG repeats expanded in myotonic dystrophies type 1 and type 2 |
| Q34542108 | RNA structure of trinucleotide repeats associated with human neurological diseases |
| Q36723012 | Reduction of the rate of protein translation in patients with myotonic dystrophy 2 |
| Q35818784 | Reduction of toxic RNAs in myotonic dystrophies type 1 and type 2 by the RNA helicase p68/DDX5 |
| Q37696972 | Repeat expansion disease: progress and puzzles in disease pathogenesis |
| Q80186511 | Reversal of fortune |
| Q39787776 | Selectable system for monitoring the instability of CTG/CAG triplet repeats in mammalian cells. |
| Q27646264 | Structural basis for the sequence-specific RNA-recognition mechanism of human CUG-BP1 RRM3 |
| Q33903996 | The 3' untranslated region of messenger RNA: A molecular 'hotspot' for pathology? |
| Q31497967 | The intrinsically unstable life of DNA triplet repeats associated with human hereditary disorders |
| Q34446513 | Triplet repeats, RNA secondary structure and toxic gain-of-function models for pathogenesis |
| Q24791029 | Untranslated regions of mRNAs |
Search more.